Pages that link to "Q46921995"
Jump to navigation
Jump to search
The following pages link to Cinacalcet treatment decreases plasma fibroblast growth factor 23 concentration in haemodialysed patients with chronic kidney disease and secondary hyperparathyroidism (Q46921995):
Displaying 4 items.
- Fibroblast Growth Factor-23-A Potential Uremic Toxin (Q28075648) (← links)
- The use of fibroblast growth factor 23 testing in patients with kidney disease (Q33835743) (← links)
- Novel Therapeutic Options for the Treatment of Mineral Metabolism Abnormalities in End Stage Renal Disease (Q36225208) (← links)
- Old and new calcimimetics for treatment of secondary hyperparathyroidism: impact on biochemical and relevant clinical outcomes (Q49166621) (← links)